Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Studies of the Effects of Influenza Antiviral Agents, Funding Opportunity Announcement (FOA) IP07-003, and Epidemiology of Influenza in Tropical Developing Countries, FOA IP07-004, 31838 [E7-11100]
Download as PDF
<![CDATA[
31838
Federal Register / Vol. 72, No. 110 / Friday, June 8, 2007 / Notices
to complete. A demographic
information form will take all
participants an additional five minutes
to complete. The total estimated annual
burden to the public is 202 hours.
contribute to risk for HIV infection. The
focus groups and interviews will each
take about two hours each to complete.
A screening interview for women
participants will take about 11 minutes
individual interviews will respond to
more personal questions. The
semistructured individual interviews
will explore behavioral, social, and
economic conditions that might
ESTIMATE OF ANNUALIZED BURDEN HOURS
Type of respondents
Number of respondents
Form name
Number of responses per
respondent
55
55
32
32
32
32
32
1
1
1
1
1
1
1
Average burden per response
(in hours)
African American Women Ages 18–29 Years.
Community Leaders ........................................
Dated: May 30, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–11088 Filed 6–7–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
pwalker on PROD1PC71 with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Studies of the Effects
of Influenza Antiviral Agents, Funding
Opportunity Announcement (FOA)
IP07–003, and Epidemiology of
Influenza in Tropical Developing
Countries, FOA IP07–004
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 12 p.m.–4 p.m., July
10, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of research grant applications
in response to FOA IP07–003, ‘‘Studies
of the Effects of Influenza Antiviral
Agents,’’ and FOA IP–07–004
VerDate Aug<31>2005
19:26 Jun 07, 2007
Jkt 211001
Screening Form ..............................................
Contact Form .................................................
Demographic Information Form .....................
Focus Group Guide ........................................
Individual Interview .........................................
Focus Group Guide (CL) ...............................
Demographic Information Form (CL) .............
‘‘Epidemiology of Influenza in Tropical,
Developing Countries.’’
CONTACT PERSON FOR MORE
INFORMATION: Trudy Messmer, PhD,
Scientific Review Administrator, 1600
Clifton Road, Mailstop C–19, Atlanta,
GA 30333, telephone (404) 639–3770.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: June 1, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–11100 Filed 6–7–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET) In
Accordance With Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for
Disease Control and Prevention (CDC)
Announces the Following Council
Meeting of the Aforementioned
Committee
Times and Dates:
8:30 a.m.–5:15 p.m., July 10, 2007.
8:30 a.m.–12:30 p.m., July 11, 2007.
Place: Corporate Square, Building 8, 1st
Floor Conference Room, Atlanta, Georgia
30333, telephone (404)639–8317.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
8/60
3/60
5/60
115/60
2
115/60
5/60
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary, Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters to be Discussed: Agenda items
include issues pertaining to Tuberculosis and
Immigration, Extensively Drug Resistant
Tuberculosis Preparedness Planning; and
Special Issues in Extensively Drug Resistant
Tuberculosis Surveillance and Control and
other related tuberculosis issues. Agenda
items are subject to change as priorities
dictate.
Contact Person for More Information:
Margie Scott-Cseh, National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention, 1600 Clifton Road, NE, M/S E–
07, Atlanta, Georgia 30333, telephone
(404)639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: June 1, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–11089 Filed 6–7–07; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\08JNN1.SGM
08JNN1
]]>Agencies
[Federal Register Volume 72, Number 110 (Friday, June 8, 2007)]
[Notices]
[Page 31838]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Studies of the Effects of Influenza Antiviral Agents,
Funding Opportunity Announcement (FOA) IP07-003, and Epidemiology of
Influenza in Tropical Developing Countries, FOA IP07-004
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting of the aforementioned Special
Emphasis Panel.
Time and Date: 12 p.m.-4 p.m., July 10, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of research grant applications in response
to FOA IP07-003, ``Studies of the Effects of Influenza Antiviral
Agents,'' and FOA IP-07-004 ``Epidemiology of Influenza in Tropical,
Developing Countries.''
CONTACT PERSON FOR MORE INFORMATION: Trudy Messmer, PhD, Scientific
Review Administrator, 1600 Clifton Road, Mailstop C-19, Atlanta, GA
30333, telephone (404) 639-3770.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: June 1, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-11100 Filed 6-7-07; 8:45 am]
BILLING CODE 4163-18-P
